Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2023
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
NeuroHagana is a biotech startup focused on preventing permanent disabilities caused by spinal cord injury, traumatic brain injury, and stroke. They are developing an immediate injectable neuro-protective treatment that works by reducing glutamic concentration in neuronal tissue, thereby saving tissue and preventing secondary damage. The treatment has shown strong therapeutic efficacy without side effects in preclinical models for spinal cord injury at Tel Aviv University.
Headcount over time
From 7 (2024-11) to 5 (2025-05) · -2 (-29%) · 2 points · source: Finder history + radar grounding
Q&A
- What is NeuroHagana's primary focus?
- NeuroHagana develops an injectable emergency treatment for neurotrauma, aiming to prevent permanent disabilities by protecting against Glutamate Excitotoxicity.
- When was NeuroHagana founded?
- NeuroHagana was founded in March 2023.
- What is the current employee count for NeuroHagana?
- NeuroHagana has 5 employees, falling into the 1-10 employee bucket.
- What is the current funding stage of NeuroHagana?
- NeuroHagana is currently in the Pre-Funding stage.
- In which sector does NeuroHagana primarily operate?
- NeuroHagana's primary sector is Health Tech & Life Sciences, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What are the initial applications for NeuroHagana's treatment?
- The first applications for NeuroHagana's treatment will be for Spinal Cord Injury, initially in Europe and the USA, with future applications for Traumatic Brain Injury and Stroke.
- Has NeuroHagana's technology been pre-clinically validated?
- Yes, NeuroHagana's technology has been pre-clinically validated in animal models of Spinal Cord Injury, Traumatic Brain Injury, and Athletes Concussion, with no reported side effects.
- Does NeuroHagana hold any patents?
- Yes, NeuroHagana holds 1 patent.
Team · 1
Angela Ruban
Founder · Co-Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
treatmentsneurosciencebiotechnologypharmaceuticalsneurologydisabilities
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | neurohagana.com |
|---|---|
| linkedin.com/in/angela-ruban-a8b71423/ |
Identifiers & details
| Legal name | NeuroHagana Ltd. |
|---|---|
| Founded | 2023 |
| Employees (exact) | 5 |
Radar intelligence
Web history (Wayback)
| Domain | neurohagana.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516776986 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-03-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 6 — shares_capital (2), annual_report (2), people (1), violation (1) |
| Registered address | יונה הנביא 20 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-11 | הקצאת מניות |
| 2026-06-11 | הגדלה של הון רשום |
| 2026-06-01 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-06-01 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-06-01 | עדכון בעלי תפקידים |
| 2026-06-01 | עדכון הפרה |